Novel drug discovery platform for spinocerebellar ataxia, using fluorescence technology targeting β-III-spectrin is a research paper published in Journal of Biological Chemistry (2020). On theSindex it has a DataRank of 0. It has been cited 11 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: R37AG026160
National Institutes of Health
Grant: R01HL139065
National Institutes of Health
Grant: R01GM044757
National Institutes of Health
Grant: R15NS116511
National Institutes of Health
Grant: R61NS111075
National Institutes of Health
Grant: GM027906
NIGMS NIH HHS
Grant: R01 GM027906
NINDS NIH HHS
Grant: R33 NS111075
MeSH Terms
Keywords